Marketing-authorisation holder · United States

Wisconsin

United States1 medicine1 country

1 medicine in 1 country, as authorisation holder.

Its medicines

Group structure

Part of

WisconsinPharmaceutical group

Other companies in the group

United States2

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

1 medicine

Medicine	Substance	Country	Status	Authorised
FLUDEOXYGLUCOSE F1818 10-100mCi/ML \| 18 10-100mCi/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 18 20-150mCi/ML \| 18 20-200mCi/ML \| 18 20-200mCi/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 18 20-240mCi/ML \| 18 20-300mCi/ML \| 18 20-400mCi/ML \| 18 20-500mCi/ML \| 18 · Injectable	Fludeoxyglucose f-18	United States	Marketed	2004

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Marketing-authorisation holder · United States

Wisconsin

United States1 medicine1 country

1 medicine in 1 country, as authorisation holder.

Its medicines

Group structure

Part of

WisconsinPharmaceutical group

Other companies in the group

United States2

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine in the registers under its name, current ones first.

1 medicine

Medicine	Substance	Country	Status	Authorised
FLUDEOXYGLUCOSE F1818 10-100mCi/ML \| 18 10-100mCi/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 18 20-150mCi/ML \| 18 20-200mCi/ML \| 18 20-200mCi/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 18 20-240mCi/ML \| 18 20-300mCi/ML \| 18 20-400mCi/ML \| 18 20-500mCi/ML \| 18 · Injectable	Fludeoxyglucose f-18	United States	Marketed	2004

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	1	1	0	Companies All medicines

Top substances

The active substances in most of its medicines.

Fludeoxyglucose f-181 medicine

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Report an error or request removalCorrections from the company itself are welcome.

At a glance

Type: Marketing-authorisation holder
Group: Wisconsin
Headquarters: United States
Medicines: 1
Countries: 1
Roles: Authorisation holder

United States: more companies

Ranked by their number of medicines.

Show all

Group structure

Part of

Other companies in the group

🇺🇸United States2

Medicines

Know your medicines, with the sources.

Group structure

Part of

Other companies in the group

🇺🇸United States2

Medicines

Know your medicines, with the sources.

Countries

Top substances

Sources and licences

At a glance

United States2

United States2